| 2024-03-11 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP, Chief Commercial Officer | 7,345 0.0076% | $65.61 | $481,931 | +3.8% | |
| 2024-03-07 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP, Chief Commercial Officer | 13,132 0.0135% | $66.57 | $874,179 | +1.83% | |
| 2024-02-26 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP, Chief Commercial Officer | 7,907 0.008% | $70.13 | $554,491 | -5.04% | |
| 2024-02-02 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP, Chief Commercial Officer | 11,860 0.0121% | $67.15 | $796,367 | +1.75% | |
| 2023-11-06 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP, Chief Commercial Officer | 42,393 0.0437% | $55.63 | $2.36M | +20.23% | |
| 2023-08-07 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP, Chief Commercial Officer | 55,300 0.0575% | $58.79 | $3.25M | +11.66% | |
| 2023-03-28 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP, Chief Commercial Officer | 15,604 0.016% | $54.31 | $847,380 | +11.39% | |
| 2023-03-13 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP, Chief Commercial Officer | 3,758 0.0039% | $44.98 | $169,042 | +35.93% | |
| 2023-03-10 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP, Chief Commercial Officer | 8,550 0.0089% | $43.34 | $370,557 | +38.64% | |
| 2023-03-01 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP, Chief Commercial Officer | 7,241 0.0077% | $50.01 | $362,122 | +23.3% | |
| 2023-02-24 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP, Chief Commercial Officer | 4,046 0.0042% | $47.12 | $190,648 | +27.97% | |
| 2023-02-21 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP, Chief Commercial Officer | 3,898 0.0041% | $47.01 | $183,246 | +29.6% | |
| 2022-04-08 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP, Chief Commercial Officer | 14,885 0.0159% | $65.14 | $969,609 | -20.28% | |
| 2022-02-24 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP, Chief Commercial Officer | 7,906 0.0083% | $52.21 | $412,810 | -2.17% | |
| 2022-02-22 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP, Chief Commercial Officer | 11,139 0.0122% | $55.29 | $615,827 | -3.92% | |
| 2022-01-10 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP, Chief Commercial Officer | 20,948 0.0225% | $40.78 | $854,255 | +29.07% | |
| 2021-10-18 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP, Chief Commercial Officer | 13,448 0.0162% | $40.86 | $549,551 | +24.91% | |
| 2021-02-19 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP, Chief Commercial Officer | 5,184 0.0064% | $39.22 | $203,308 | -4.23% | |
| 2021-01-11 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP, Chief Commercial Officer | 9,684 0.012% | $32.02 | $310,082 | +15.93% | |
| 2020-10-16 | Sale | Intra-Cellular Therapies, Inc. ITCI | EVP, Chief Commercial Officer | 13,584 0.0172% | $26.80 | $364,051 | +29.12% |